Search

8 Jul 2024: Biophonics. Biophonics. Enabling widespread early detection of valvularheart disease with a unique medical device. Website. Overview. Nearly 2 million people in the UK suffer from significant valvular heart disease,yet more than half remain

8 Jul 2024: OutSee. OutSee. Discovering novel drug targets using an innovativeAI genomics technology that uncovers disease-modulating biological mechanisms. Website. Overview. OutSee is being launched to take advantage of the opportunity to exploit large-scale

8 Jul 2024: PredictImmune. PredictImmune. Helping patients diagnosed with chronic immune-mediated disorders to live normal and healthy lives. Website. Overview. PredictImmune developes prognostic assays that predict disease progressionfor patients with

8 Jul 2024: 360 implant to treat spinal cord injuries. Background. The spinal cord is a key organ of the nervous system, which is in charge ofcarrying information around the body. Every year between 250,000-500,000people suffer injuries to the spinal cord

8 Jul 2024: MutREAD – Mutational Signature Detection byRestriction Enzyme-Associated DNA Sequencing. Background. The successful application of mutational signatures in clinical settingsrequires availability of a cost-effective, scalable detection method that

8 Jul 2024: Real-time autofocus for videomicroscopy. Background. Video-microscopy of living subjects is hampered by their movement out of themicroscope’s focal plane. At video frame-rates, manual refocusing becomesimpossible; therefore, autofocus is required.

8 Jul 2024: Low-Cost Trace Analyte Detection with ReusableSERS Substrates. Background. To move beyond current low-cost sensors, towards measuring trace analytes inapplications such as healthcare monitoring, geology and mineralogy, pollutionmonitoring, and

8 Jul 2024: Neonatal wireless transmission system. Background. When babies are in intensive care, they need to be continuously monitored.This requires multiple sensors with separate wires. These wires can becometangled and make clinical care harder. Parents

8 Jul 2024: Mouse Models of Essential Thrombocythemia (ET)and Myelofibrosis (MF) – Available for PreclinicalStudies. Background. Researchers at the University of Cambridge have generated fully characterised,conditional knock-in mouse models for essential

8 Jul 2024: Implantable drug delivery device targeting braintumours. Background. Successful treatment of brain cancers is limited due to the difficulty ofdelivering therapies to difficult-to-access tumours. There is also a need for newtechnologies able to